Ece Esin

754 total citations
33 papers, 315 citations indexed

About

Ece Esin is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ece Esin has authored 33 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 9 papers in Epidemiology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ece Esin's work include Cancer Treatment and Pharmacology (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Ece Esin is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Ece Esin collaborates with scholars based in Türkiye, India and Antigua and Barbuda. Ece Esin's co-authors include Şuayib Yalçın, Cem Şimşek, Şahin Laçin, Tuğba Akın Telli, Şuayib Yalçın, Meltem Halil, Mustafa Cankurtaran, Yüksel Ürün, Deniz Yüce and Nuriye Özdemir and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Ece Esin

27 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ece Esin Türkiye 9 152 65 60 50 39 33 315
Su‐Han Jin China 12 72 0.5× 112 1.7× 61 1.0× 84 1.7× 48 1.2× 31 319
Nikolaus Möckelmann Germany 13 148 1.0× 81 1.2× 86 1.4× 43 0.9× 196 5.0× 32 396
Ajay Kumar Chaudhary India 12 105 0.7× 166 2.6× 41 0.7× 97 1.9× 62 1.6× 32 503
Μαρία Σαμαρά Greece 13 74 0.5× 155 2.4× 21 0.3× 63 1.3× 67 1.7× 37 544
Debbie Piktel United States 12 88 0.6× 156 2.4× 48 0.8× 67 1.3× 59 1.5× 23 401
Angel Yordanov Bulgaria 9 109 0.7× 88 1.4× 70 1.2× 42 0.8× 92 2.4× 101 411
Guangyu Bai China 13 177 1.2× 112 1.7× 136 2.3× 75 1.5× 63 1.6× 33 401
Eun‐Heui Jin South Korea 11 67 0.4× 196 3.0× 27 0.5× 117 2.3× 31 0.8× 25 394
Hidetaka Arita Japan 11 171 1.1× 172 2.6× 35 0.6× 128 2.6× 62 1.6× 19 403
Joshua Leinwand United States 9 144 0.9× 108 1.7× 102 1.7× 35 0.7× 71 1.8× 18 362

Countries citing papers authored by Ece Esin

Since Specialization
Citations

This map shows the geographic impact of Ece Esin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ece Esin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ece Esin more than expected).

Fields of papers citing papers by Ece Esin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ece Esin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ece Esin. The network helps show where Ece Esin may publish in the future.

Co-authorship network of co-authors of Ece Esin

This figure shows the co-authorship network connecting the top 25 collaborators of Ece Esin. A scholar is included among the top collaborators of Ece Esin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ece Esin. Ece Esin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bilgetekin, İrem, et al.. (2020). Enzalutamide Treatment in Metastatic Castration-resistant Prostate Cancer: Before and after Docetaxel. Journal of College of Physicians And Surgeons Pakistan. 30(8). 815–821. 1 indexed citations
3.
Laçin, Şahin, et al.. (2020). Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience. The Turkish Journal of Gastroenterology. 31(2). 91–98. 2 indexed citations
4.
Telli, Tuğba Akın, Ece Esin, & Şuayib Yalçın. (2020). Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) s: A Single-Center Experience. Balkan Medical Journal. 37(5). 281–286. 2 indexed citations
5.
Esin, Ece, et al.. (2019). Controversies in the efficacy of adjuvant chemotherapy in different epithelial ovarian carcinoma histologies. SHILAP Revista de lepidopterología. 5(3). 96–99. 1 indexed citations
6.
Sağlam, Arzu, Ece Esin, Mutlu Hayran, Bariş Boyraz, & Ayşegül Üner. (2018). Distribution of lymphomas in Turkey: data of 4239 cases from a single institution using the WHO classification. TURKISH JOURNAL OF MEDICAL SCIENCES. 48(5). 1013–1023. 2 indexed citations
7.
Karadurmuş, Nuri, et al.. (2018). Prognostic value of ABO blood group in patients with nonseminomatous testicular cancer who treated with autologous stem cell transplantation. SHILAP Revista de lepidopterología. 4(2). 70–73. 2 indexed citations
8.
Esin, Ece, et al.. (2018). Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey. The Turkish Journal of Gastroenterology. 29(4). 411–418.
9.
Esin, Ece, et al.. (2017). Short term real world safety data of pertuzumab use in HER2 targeted treatment of metastatic breast cancer. SHILAP Revista de lepidopterología. 4(1). 11–14.
10.
Esin, Ece. (2017). Clinical Applications of Immunotherapy Combination Methods and New Opportunities for the Future. BioMed Research International. 2017. 1–10. 7 indexed citations
11.
Yalçın, Şuayib, et al.. (2016). A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer. OncoTargets and Therapy. Volume 9. 4815–4820. 8 indexed citations
12.
Babacan, Taner, Orhan Efe, Hakan Büyükhatipoğlu, et al.. (2015). Efficacy of Capecitabine Monotherapy as the First-line Treatment of Metastatic HER2-negative Breast Cancer. Tumori Journal. 101(4). 418–423. 8 indexed citations
13.
Hayran, Mutlu, Deniz Yüce, Ece Esin, et al.. (2015). Quality of Life Domains Associated With Readmission. Value in Health. 18(3). A211–A212. 1 indexed citations
14.
Yalçın, Şuayib, et al.. (2015). Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen. OncoTargets and Therapy. 8. 1039–1039. 10 indexed citations
15.
Esin, Ece, Ali̇ Ergen, Mustafa Cankurtaran, et al.. (2015). Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder. Aging & Mental Health. 19(3). 217–223. 23 indexed citations
16.
Esin, Ece & Şuayib Yalçın. (2015). Maintenance strategy in metastatic colorectal cancer: A systematic review. Cancer Treatment Reviews. 42. 82–90. 45 indexed citations
17.
Keskin, Özge, Sercan Aksoy, Taner Babacan, et al.. (2014). Impact of the obesity on lymph node status in operable breast cancer patients.. PubMed. 18(4). 824–30. 9 indexed citations
18.
Esin, Ece, et al.. (2014). A retrospective study of fractures in neonatal calves: 181 cases (2002-2012).. Pakistan Veterinary Journal. 34(2). 247–250. 8 indexed citations
19.
Hayran, Mutlu, Deniz Yüce, Ece Esin, et al.. (2014). Association of Health Care Cost with Quality of Life for Various Types of Cancers. Value in Health. 17(7). A631–A631. 1 indexed citations
20.
Yalçın, Şuayib & Ece Esin. (2014). Neuropathic cancer pain: What we are dealing with? How to manage it?. OncoTargets and Therapy. 7. 599–599. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026